Examining HRSA's Oversight of the 340B Drug Pricing Program
July 18, 2017
House Committee on Energy and Commerce: Subcommittee on Oversight and Investigations
Erin Bliss, Assistant Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
Testimony Statement PDF, 541.1 KB